Michael Rowley

Michael Rowley publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Michael Rowley sits on this spectrum.

Michael Rowley D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Rowley sits on this spectrum.

Overview

Best Publications

• Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection

  Vincenzo Summa;Alessia Petrocchi;Fabio Bonelli;Benedetta Crescenzi

  744
  Citations

• Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors.

  Philip Jones;Sergio Altamura;Julia Boueres;Federica Ferrigno

  418
  Citations

• MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants

  Vincenzo Summa;Steven W. Ludmerer;John A. McCauley;Christine Fandozzi

  286
  Citations

• Mechanism of Action and Antiviral Activity of Benzimidazole-Based Allosteric Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase

  Licia Tomei;Sergio Altamura;Linda Bartholomew;Antonino Biroccio

  240
  Citations

• Interdomain Communication in Hepatitis C Virus Polymerase Abolished by Small-Molecule Inhibitors Bound to a Novel Allosteric Site

  Stefania Di Marco;Cinzia Volpari;Licia Tomei;Sergio Altamura

  210
  Citations

• Fluorination of 3-(3-(Piperidin-1-yl)propyl)indoles and 3-(3-(Piperazin-1-yl)propyl)indoles Gives Selective Human 5-HT1D Receptor Ligands with Improved Pharmacokinetic Profiles

  M. B. Van Niel;I. Collins;M. S. Beer;H. B. Broughton

  209
  Citations

• Niraparib: A Poly(ADP-ribose) Polymerase (PARP) Inhibitor for the Treatment of Tumors with Defective Homologous Recombination.

  Philip Jones;Keith Wilcoxen;Michael Rowley;Carlo Toniatti

  204
  Citations

• Current and novel approaches to the drug treatment of schizophrenia.

  Michael Rowley;Linda J. Bristow;Peter H. Hutson

  203
  Citations

• Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor.

  Steven Harper;John A McCauley;Michael T Rudd;Marco Ferrara

  199
  Citations

• Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists.

  Michael Rowley;Janusz J. Kulagowski;Alan P. Watt;Denise Rathbone

  179
  Citations

• 3'-(Arylmethyl)- and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones : orally active antagonists of the glycine site on the NMDA receptor

  Kulagowski Jj;Baker R;Curtis Nr;Leeson Pd

  162
  Citations

• 4,5-dihydroxypyrimidine carboxamides and N-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species.

  Vincenzo Summa;Alessia Petrocchi;Victor G. Matassa;Cristina Gardelli

  161
  Citations

• Total synthesis of (+)-ophiobolin C

  Michael Rowley;Masamitsu Tsukamoto;Yoshito Kishi

  156
  Citations

• 3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional delectivity for alpha 2/alpha 3-subtypes of human GABA(A) receptor-ion channels

  Ian Collins;Christopher Moyes;William B Davey;Michael Rowley

  155
  Citations

• 5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole: a potent, selective antagonist at human cloned dopamine D4 receptors.

  Rowley M;Broughton Hb;Collins I;Baker R

  153
  Citations

• 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists.

  M Rowley;D J Hallett;S Goodacre;C Moyes

  146
  Citations

• Tetrazole thioacetanilides: potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant.

  Ester Muraglia;Olaf D. Kinzel;Ralph Laufer;Michael D. Miller

  128
  Citations

• 3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systemically active anticonvulsants acting by antagonism at the glycine site of the N-methyl-D-aspartate receptor complex.

  Rowley M;Leeson Pd;Stevenson Gi;Moseley Am

  125
  Citations

• Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitors.

  Paola Pace;M. Emilia Di Francesco;Cristina Gardelli;Steven Harper

  122
  Citations

• Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-N-acetamide allosteric inhibitors of the viral NS5B polymerase.

  Steven Harper;Salvatore Avolio;Barbara Pacini;Marcello Di Filippo

  121
  Citations